BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32952075)

  • 21. [Age-related differences in the management and outcome of acute coronary syndrome under the chest pain center model: a multicenter retrospective study].
    Li S; Ding X; Ye T; Cheng L; Cui C; Zhang Y; Zhu F; Jiang X; Cai L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Mar; 33(3):318-323. PubMed ID: 33834973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of Chinese herbal medicines on acute coronary syndrome with renal insufficiency after percutaneous coronary intervention.
    Zhang DW; Wang SL; Wang PL; Du JP; Gao ZY; Wang CL; Xu H; Shi DZ
    J Ethnopharmacol; 2020 Feb; 248():112354. PubMed ID: 31689480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The incidence and risk factors of stroke in patients with acute myocardial infarction treated invasively and concomitant impaired renal function.
    Podolecki T; Lenarczyk R; Kowalczyk J; Świątkowski A; Chodór P; Pruszkowska-Skrzep P; Sędkowska A; Poloński L; Kalarus Z
    Cardiol J; 2013; 20(6):672-8. PubMed ID: 23677725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary intervention.
    Loncar G; Barthelemy O; Berman E; Kerneis M; Petroni T; Payot L; Choussat R; Silvain J; Collet JP; Helft G; Montalescot G; Le Feuvre C
    Arch Cardiovasc Dis; 2015 Nov; 108(11):554-62. PubMed ID: 26184868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute coronary syndrome in octogenarians: association between percutaneous coronary intervention and long-term mortality.
    Barywani SB; Li S; Lindh M; Ekelund J; Petzold M; Albertsson P; Lund LH; Fu ML
    Clin Interv Aging; 2015; 10():1547-53. PubMed ID: 26451095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed PCI is not beneficial for STEMI patients with impaired renal function: a retrospective cohort study.
    Lao Y; Chen K; Feng L; Yuan Y; Zhang J; Zhang L; Huang X; Li M; Wu Z; Bin J; Liao Y
    BMC Cardiovasc Disord; 2023 May; 23(1):263. PubMed ID: 37208590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Kowalczyk J; Lenarczyk R; Kowalski O; Swiatkowski A; Stabryła-Deska J; Kurek T; Honisz G; Kukulski T; Gasior M; Kalarus Z
    Kardiol Pol; 2007 Jun; 65(6):635-43; discussion 644. PubMed ID: 17629825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contemporary Antiplatelet Treatment in Acute Coronary Syndrome Patients with Impaired Renal Function Undergoing Percutaneous Coronary Intervention.
    Davlouros P; Xanthopoulou I; Goudevenos J; Hamilos M; Vavuranakis E; Sitafidis G; Kanakakis I; Deftereos S; Alexopoulos D
    Cardiology; 2017; 138(3):186-194. PubMed ID: 28750372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trajectory of renal function change and kidney injury after percutaneous coronary intervention in patients with stable coronary artery disease.
    Deguchi Y; Saito Y; Nakao M; Shiraishi H; Sakamoto N; Kobayashi S; Kobayashi Y
    Heart Vessels; 2021 Mar; 36(3):315-320. PubMed ID: 32930865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Five-year mortality outcomes in patients with chronic kidney disease undergoing percutaneous coronary intervention.
    Patel AD; Ibrahim M; Swaminathan RV; Minhas IU; Kim LK; Venkatesh P; Feldman DN; Minutello RM; Bergman GW; Wong SC; Singh HS
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):E124-E132. PubMed ID: 27519355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention.
    Tricoci P; Newby LK; Clare RM; Leonardi S; Gibson CM; Giugliano RP; Armstrong PW; Van de Werf F; Montalescot G; Moliterno DJ; Held C; Aylward PE; Wallentin L; Harrington RA; Braunwald E; Mahaffey KW; White HD
    JACC Cardiovasc Interv; 2018 May; 11(9):856-864. PubMed ID: 29747915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of remote ischemic preconditioning on contrast induced nephropathy after percutaneous coronary intervention in patients with acute coronary syndrome.
    Zhou F; Song W; Wang Z; Yin L; Yang S; Yang F; Song Z; Song Y; Zhang H; Qiao F; Zhang Z
    Medicine (Baltimore); 2018 Jan; 97(2):e9579. PubMed ID: 29480853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal failure in patients with ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention: Predictors, clinical and angiographic features, and outcomes.
    Vavalle JP; van Diepen S; Clare RM; Hochman JS; Weaver WD; Mehta RH; Pieper KS; Patel MR; Patel UD; Armstrong PW; Granger CB; Lopes RD
    Am Heart J; 2016 Mar; 173():57-66. PubMed ID: 26920597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An overview of percutaneous coronary intervention in dialysis patients: Insights from a Japanese nationwide registry.
    Numasawa Y; Inohara T; Ishii H; Yamaji K; Hirano K; Kohsaka S; Sawano M; Kuno T; Kodaira M; Uemura S; Kadota K; Amano T; Nakamura M;
    Catheter Cardiovasc Interv; 2019 Jul; 94(1):E1-E8. PubMed ID: 30467967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of baseline estimated glomerular filtration rate on inhospital outcomes of patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: A China acute myocardial infarction registry study.
    Jia S; Zhao Y; Yang J; Zhao X; Xu H; Gao R; Wang Q; Li J; Yuan J; Yang Y
    Catheter Cardiovasc Interv; 2019 Feb; 93(S1):793-799. PubMed ID: 30637931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-ST elevation acute coronary syndrome in patients aged 80 years or older in Vietnam: An observational study.
    Nguyen TV; Bui KX; Tran KD; Le D; Nguyen TN
    PLoS One; 2020; 15(6):e0233272. PubMed ID: 32542011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic comparison between creatinine-based glomerular filtration rate formulas for the prediction of 10-year outcome in patients with non-ST elevation acute coronary syndrome treated by percutaneous coronary intervention.
    Ballo P; Chechi T; Spaziani G; Fibbi V; Conti D; Ferro G; Nigrelli S; Dattolo P; Fazi A; Santoro GM; Zuppiroli A; Pizzarelli F
    Eur Heart J Acute Cardiovasc Care; 2018 Dec; 7(8):689-702. PubMed ID: 29064262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic utility of myocardial blush grade after PCI in patients with NSTE-ACS: Analysis from the ACUITY trial.
    Ng VG; Lansky AJ; Toro S; Parise H; Cristea E; Mehran R; Stone GW
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):215-24. PubMed ID: 25641255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of the index of microcirculatory resistance after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome.
    Murai T; Yonetsu T; Kanaji Y; Usui E; Hoshino M; Hada M; Hamaya R; Kanno Y; Lee T; Kakuta T
    Catheter Cardiovasc Interv; 2018 Nov; 92(6):1063-1074. PubMed ID: 29446567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The burden of major adverse cardiac events in patients with coronary artery disease.
    Tsai IT; Wang CP; Lu YC; Hung WC; Wu CC; Lu LF; Chung FM; Hsu CC; Lee YJ; Yu TH
    BMC Cardiovasc Disord; 2017 Jan; 17(1):1. PubMed ID: 28052754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.